Marco Breinig
- Co-authors
- Michael BoutrosFlorian HeigwerPeter SchirmacherMichael KernJan WinterDarjus F. TschaharganehScott W. LoweEmma M. Schatoff
- Topics
- CRISPR and Genetic Engineering (7 papers)RNA regulation and disease (4 papers)Eicosanoids and Hypertension Pharmacology (3 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Marco Breinig
20 papers receiving 811 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 653
- Genetics 128
- Oncology 104
- Cancer Research 80
- Epidemiology 63
Countries citing papers authored by Marco Breinig
This map shows the geographic impact of Marco Breinig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Breinig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Breinig more than expected).
Fields of papers citing papers by Marco Breinig
This network shows the impact of papers produced by Marco Breinig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Breinig. The network helps show where Marco Breinig may publish in the future.
Co-authorship network of co-authors of Marco Breinig
This figure shows the co-authorship network connecting the top 25 collaborators of Marco Breinig. A scholar is included among the top collaborators of Marco Breinig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Breinig. Marco Breinig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 8 | |
| 4 | 251 | |
| 5 | 49 | |
| 6 | 56 | |
| 7 | 51 | |
| 8 | 53 | |
| 9 | 47 | |
| 10 | 57 | |
| 11 | 21 | |
| 12 | 15 | |
| 13 | 2 | |
| 14 | 62 | |
| 15 | Expression and mutational status of PDGFR in thymic tumours. | 6 |
| 16 | 35 | |
| 17 | 34 | |
| 18 | 20 | |
| 19 | 46 | |
| 20 | [Significance of cyclooxygenase-2 as a chemotherapeutic target in hepatocellular carcinoma]. | 4 |
About Marco Breinig
Marco Breinig is a scholar working on Aging, Biochemistry and Genetics, having authored 20 papers that have together received 822 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), RNA regulation and disease (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Business and International Management (51 citations), Aging (41 citations) and Molecular Biology (653 citations). Marco Breinig has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Michael Boutros, Florian Heigwer, Peter Schirmacher, Michael Kern, Jan Winter, Darjus F. Tschaharganeh, Scott W. Lowe, Emma M. Schatoff, Junwei Shi and María Paz Zafra. Their work appears in journals such as Nucleic Acids Research, Nature Biotechnology and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.